ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Hormone therapy in urogenital health after menopause
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 217212" data-attributes="member: 13851"><p><strong>Research agenda </strong></p><p></p><p><em><strong>*Prospective studies are needed to describe the course of symptoms across the menopausal transition and to investigate the role of estrogens, androgens, and aging per se in the manifestation of specific signs associated with GSM</strong></em></p><p><em><strong></strong></em></p><p><em><strong>*Comparative studies should be conducted to prove specific effects of different treatments on the constellation of signs and symptoms of GSM, taking into account age, sexual activity, and comorbidities </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*It is fundamental to explore strategies to ensure long-term adherence to GSM therapies in order to improve efficacy</strong></em></p><p><em><strong></strong></em></p><p><strong><em>*Safety should be a priority in postmenopausal women with contraindications to hormonal treatments and further research should be conducted by tailoring the type and dose of drugs and by expanding the area of non-hormonal options</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 217212, member: 13851"] [B]Research agenda [/B] [I][B]*Prospective studies are needed to describe the course of symptoms across the menopausal transition and to investigate the role of estrogens, androgens, and aging per se in the manifestation of specific signs associated with GSM *Comparative studies should be conducted to prove specific effects of different treatments on the constellation of signs and symptoms of GSM, taking into account age, sexual activity, and comorbidities *It is fundamental to explore strategies to ensure long-term adherence to GSM therapies in order to improve efficacy [/B][/I] [B][I]*Safety should be a priority in postmenopausal women with contraindications to hormonal treatments and further research should be conducted by tailoring the type and dose of drugs and by expanding the area of non-hormonal options[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Hormone therapy in urogenital health after menopause
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top